Female C57BL/6 mice (8 to10 weeks old) were purchased from Japan SLC (Hamamatsu, Japan). Animals were maintained according to guidelines for the ethical use of animals in research at Hiroshima University. VEGF-siRNA (sense strand, 5′-CGAUGAAGCCCUGGAGUGCTT-3′; antisense strand, 5′-GCACUCCAGGGCUUCAUCGTT-3′) and non-target siRNA (sense strand, 5′-UACUAUUCGACACGCGAAGTT-3′; antisense strand, 5′-CUUCGCGUGUCGAAUAGUATT-3′) were purchased from Hokkaido System Science (Sapporo, Japan). Chitosan (molecular weight [MW] 2,000–5,000, water-soluble; Wako Pure Chemical Industries, Osaka, Japan), D-(-)-mannitol (Wako Pure Chemical Industries) and L-leucine (Sigma-Aldrich, St. Louis, MO, USA) were used as a non-viral vector and excipient, respectively.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.